The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus
Chronic hepatitis C, which is caused by the hepatitis C virus, represents a substantial health threat to humans and causes approximately 700,000 deaths each year worldwide. However, 30 years after the discovery of this virus in 1989, nearly perfect antiviral drugs that can clear up to 95% of this vi...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2981241caf4442bfb09afea954fef0f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2981241caf4442bfb09afea954fef0f0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2981241caf4442bfb09afea954fef0f02021-11-28T04:33:13ZThe 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus2319-417010.1016/j.bj.2021.07.001https://doaj.org/article/2981241caf4442bfb09afea954fef0f02021-10-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2319417021000883https://doaj.org/toc/2319-4170Chronic hepatitis C, which is caused by the hepatitis C virus, represents a substantial health threat to humans and causes approximately 700,000 deaths each year worldwide. However, 30 years after the discovery of this virus in 1989, nearly perfect antiviral drugs that can clear up to 95% of this virus have been developed due to numerous biomedical research studies and cooperation among members of the hepatitis C community. Because of these advances, the WHO announced a goal to eliminate the hepatitis C virus globally by 2030. Reviewing prior advances in detail, it is clear that all these achievements are based on initial seminal research conducted by the three 2020 Nobel laureates in medicine, namely, Harvey J. Alter, Michael Houghton and Charles M. Rice. In this short essay, we describe the seminal studies conducted by these authors. At the same time, the impacts of the contributions of these researchers on subsequent developments in research and in the treatment of chronic hepatitis C are honored.Chun-Yen LinRong-Nan ChienI-Shyan SheenElsevierarticleMedicine (General)R5-920Biology (General)QH301-705.5ENBiomedical Journal, Vol 44, Iss 5, Pp 567-569 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 Biology (General) QH301-705.5 |
spellingShingle |
Medicine (General) R5-920 Biology (General) QH301-705.5 Chun-Yen Lin Rong-Nan Chien I-Shyan Sheen The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus |
description |
Chronic hepatitis C, which is caused by the hepatitis C virus, represents a substantial health threat to humans and causes approximately 700,000 deaths each year worldwide. However, 30 years after the discovery of this virus in 1989, nearly perfect antiviral drugs that can clear up to 95% of this virus have been developed due to numerous biomedical research studies and cooperation among members of the hepatitis C community. Because of these advances, the WHO announced a goal to eliminate the hepatitis C virus globally by 2030. Reviewing prior advances in detail, it is clear that all these achievements are based on initial seminal research conducted by the three 2020 Nobel laureates in medicine, namely, Harvey J. Alter, Michael Houghton and Charles M. Rice. In this short essay, we describe the seminal studies conducted by these authors. At the same time, the impacts of the contributions of these researchers on subsequent developments in research and in the treatment of chronic hepatitis C are honored. |
format |
article |
author |
Chun-Yen Lin Rong-Nan Chien I-Shyan Sheen |
author_facet |
Chun-Yen Lin Rong-Nan Chien I-Shyan Sheen |
author_sort |
Chun-Yen Lin |
title |
The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus |
title_short |
The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus |
title_full |
The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus |
title_fullStr |
The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus |
title_full_unstemmed |
The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus |
title_sort |
2020 nobel prize in medicine for the discovery of hepatitis c virus: an epic saga of the fight against a troublesome virus |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/2981241caf4442bfb09afea954fef0f0 |
work_keys_str_mv |
AT chunyenlin the2020nobelprizeinmedicineforthediscoveryofhepatitiscvirusanepicsagaofthefightagainstatroublesomevirus AT rongnanchien the2020nobelprizeinmedicineforthediscoveryofhepatitiscvirusanepicsagaofthefightagainstatroublesomevirus AT ishyansheen the2020nobelprizeinmedicineforthediscoveryofhepatitiscvirusanepicsagaofthefightagainstatroublesomevirus AT chunyenlin 2020nobelprizeinmedicineforthediscoveryofhepatitiscvirusanepicsagaofthefightagainstatroublesomevirus AT rongnanchien 2020nobelprizeinmedicineforthediscoveryofhepatitiscvirusanepicsagaofthefightagainstatroublesomevirus AT ishyansheen 2020nobelprizeinmedicineforthediscoveryofhepatitiscvirusanepicsagaofthefightagainstatroublesomevirus |
_version_ |
1718408307159334912 |